GPR30 was initially identified to be widely expressed in the brain and peripheral tissues43, but high expression levels of GPR30 in ER-positive breast cancer cell line44 and a non-genomic action of E2 via GPR3045 led to the recognition of GPR30 as an oestrogen-binding receptor17,18. Here, GPER1 is linked to breast cancer.